Tumor Ablation Market to Witness an Outstanding Growth During 2019-2030 - Medtronic, Integra LifeSciences, AngioDynamics
Tumor ablation is referred to as a minimally invasive technique that is commonly used in the treatment of tumors of the liver, kidney, bone, and lung among others. It can be used as a first-line treatment or in cases of failed chemotherapy or radiotherapy or for any non-surgical candidates. Ablation systems in general comprise of a generator and a needlelike device that delivers the energy directly to the targeted tissue to cause acute cellular necrosis. The tumor ablation market is witnessing growth due to factors such as growing geriatric population and increasing cancer population. Moreover, technological advancement in ablation devices will further fuel the growth of tumor ablation over the forecast period. However, high cost of tumor ablation treatment is likely to restrain the market to a certain extent. According to the report, the global tumor Ablation is estimated to be over US$ 545.3 Mn in 2018. It is anticipated to grow at 11.1% CAGR from 2019 to 2030.Major Key Players of the Tumor Ablation Market are:
Medtronic, Integra LifeSciences Corporation, AngioDynamics, Boston Scientific Corporation, NeuWave Medical, (Johnson & Johnson Services), Galil Medical Inc. (BTG International Ltd), Misonix, HealthTronics, Inc., Sonacare Medical, MERMAID MEDICAL A/S among others.
No comments:
Post a Comment